The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Gilead Sciences Inc and Xilio Therapeutics Inc have recently announced an exclusive agreement to collaborate on the development and commercialization of Xilios Phase tumoractivated IL program
Confo Therapeutics a pioneer in the field of developing innovative medicines targeting Gprotein coupled receptors has announced today that it has received a substantial EUR million grant from Flanders
Intravacc a globally recognized contract development and manufacturing organization specializing in infectious disease and therapeutic vaccines has announced a strategic partnership with Primrose Bio
Essential Pharma a global specialty pharmaceutical group dedicated to ensuring sustainable access to
In response to significant customer demand Slingshot Biosciences is unveiling a revolutionary range of products aimed at transforming the landscape of analytical precision in cell therapy
Brain Trust Bio a leading innovator in developing treatments for central nervous system disorders has obtained approval to initiate Phase I clinical trials in Australia for its revolutionary Continuous
Andelyn Biosciences Inc a leading Contract Development and Manufacturing Organization specializing in cell and gene therapy has partnered with Grace Science LLC to facilitate the tech transfer
Human Immunology Biosciences a biotechnology company in the clinical stages of development has recently announced that the US Food and Drug Administration has granted Orphan Drug Designation
Mission Therapeutics a biotech company in the clinical stage has initiated the Phase I firstinhuman clinical trial of MTX its promising treatment aimed at modifying Parkinsons Disease
Phanes Therapeutics Inc a leading biotechnology company specializing in innovative oncology drug discovery and development made an announcement today regarding PT The US Food and Drug
